Trends in Early Drug Safety

Drug News and Perspectives

Volumn 17, Issue 2, 2004, Pages 143-148

  Armer, Richard E ^b   Morris, Ian D ^a  

^a UNIVERSITY OF YORK   (United Kingdom)

^b Oxagen Ltd   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450; CYTOCHROME P450 1A1; CYTOCHROME P450 2C9; CYTOCHROME P450 2D6; CYTOCHROME P450 2E1; CYTOCHROME P450 3A4;

CONFERENCE PAPER; DNA POLYMORPHISM; DRUG CROSS REACTIVITY; DRUG METABOLISM; DRUG RESEARCH; DRUG SURVEILLANCE PROGRAM; FOOD AND DRUG ADMINISTRATION; GENOMICS; QT PROLONGATION; SYMPOSIUM; TOXICOLOGY; UNITED KINGDOM;

ANIMALS; CLINICAL TRIALS; CYTOCHROME P-450 ENZYME SYSTEM; DRUG DESIGN; DRUG INDUSTRY; DRUG INTERACTIONS; HUMANS; LONG QT SYNDROME; MODELS, ANIMAL; PHARMACEUTICAL PREPARATIONS; TOXICOGENETICS;

EID: 2342640748     PISSN: 02140934     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (0)